How to buy Elanco Animal Health Incorporated stock

Elanco Animal Health Incorporated is a drug manufacturers-specialty & generic business based in the US. Elanco Animal Health Incorporated shares (ELAN) are listed on the NYSE and all prices are listed in US Dollars. Elanco Animal Health Incorporated employs 10,200 staff and has a trailing 12-month revenue of around 0.00.

Elanco Animal Health Incorporated share price

Use our graph to track the performance of ELAN stocks over time.

Elanco Animal Health Incorporated shares at a glance

• Key figures

Information last updated 2021-04-15.

52-week range	$18.37 - $34.81
50-day moving average	$30.90
200-day moving average	$30.47
Wall St. target price	$33.50
PE ratio	144.8889
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.25

Buy Elanco Animal Health Incorporated shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Elanco Animal Health Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Elanco Animal Health Incorporated by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Elanco Animal Health Incorporated under- or over-valued?

Valuing Elanco Animal Health Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Elanco Animal Health Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Elanco Animal Health Incorporated's P/E ratio

Elanco Animal Health Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 145x. In other words, Elanco Animal Health Incorporated shares trade at around 145x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Elanco Animal Health Incorporated's PEG ratio

Elanco Animal Health Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4299. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Elanco Animal Health Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Elanco Animal Health Incorporated's EBITDA

Elanco Animal Health Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $495.2 million.

The EBITDA is a measure of a Elanco Animal Health Incorporated's overall financial performance and is widely used to measure a its profitability.

Elanco Animal Health Incorporated financials

Revenue TTM	$3.3 billion
Operating margin TTM	0.41%
Gross profit TTM	$1.7 billion
Return on assets TTM	0.06%
Return on equity TTM	-7.99%
Profit margin	-17.11%
Book value	$17.96
Market capitalisation	$14.4 billion

TTM: trailing 12 months

Shorting Elanco Animal Health Incorporated shares

There are currently 9.2 million Elanco Animal Health Incorporated shares held short by investors – that's known as Elanco Animal Health Incorporated's "short interest". This figure is 5.6% down from 9.8 million last month.

There are a few different ways that this level of interest in shorting Elanco Animal Health Incorporated shares can be evaluated.

Elanco Animal Health Incorporated's "short interest ratio" (SIR)

Elanco Animal Health Incorporated's "short interest ratio" (SIR) is the quantity of Elanco Animal Health Incorporated shares currently shorted divided by the average quantity of Elanco Animal Health Incorporated shares traded daily (recently around 5.2 million). Elanco Animal Health Incorporated's SIR currently stands at 1.77. In other words for every 100,000 Elanco Animal Health Incorporated shares traded daily on the market, roughly 1770 shares are currently held short.

However Elanco Animal Health Incorporated's short interest can also be evaluated against the total number of Elanco Animal Health Incorporated shares, or, against the total number of tradable Elanco Animal Health Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Elanco Animal Health Incorporated's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Elanco Animal Health Incorporated shares in existence, roughly 20 shares are currently held short) or 0.0208% of the tradable shares (for every 100,000 tradable Elanco Animal Health Incorporated shares, roughly 21 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Elanco Animal Health Incorporated.

Find out more about how you can short Elanco Animal Health Incorporated stock.

Elanco Animal Health Incorporated share dividends

We're not expecting Elanco Animal Health Incorporated to pay a dividend over the next 12 months.

Elanco Animal Health Incorporated share price volatility

Over the last 12 months, Elanco Animal Health Incorporated's shares have ranged in value from as little as $18.37 up to $34.81. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Elanco Animal Health Incorporated's is 0.8451. This would suggest that Elanco Animal Health Incorporated's shares are less volatile than average (for this exchange).

Elanco Animal Health Incorporated overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. .

Frequently asked questions

• What percentage of Elanco Animal Health Incorporated is owned by insiders or institutions?

  Currently 4.191% of Elanco Animal Health Incorporated shares are held by insiders and 99.073% by institutions.

• How many people work for Elanco Animal Health Incorporated?

  Latest data suggests 10,200 work at Elanco Animal Health Incorporated.

• When does the fiscal year end for Elanco Animal Health Incorporated?

  Elanco Animal Health Incorporated's fiscal year ends in December.

• Where is Elanco Animal Health Incorporated based?

  Elanco Animal Health Incorporated's address is: 2500 Innovation Way, Greenfield, IN, United States, 46140

• What is Elanco Animal Health Incorporated's ISIN number?

  Elanco Animal Health Incorporated's international securities identification number is: US28414H1032

• What is Elanco Animal Health Incorporated's CUSIP number?

  Elanco Animal Health Incorporated's Committee on Uniform Securities Identification Procedures number is: 28414H103